Aehr Test Systems, listed on NASDAQ under the symbol AEHR, is a semiconductor company known for its innovative testing solutions. The company has a market capitalization of $1.04 billion and operates in a competitive industry. Recently, Rhea J. Posedel, a director at AEHR, sold 13,998 shares at $30.02 each, retaining 456,979 shares.
The sale by Posedel comes amid a surge in options trading for AEHR. On Wednesday, traders acquired 6,725 call options, an 88% increase from the average volume of 3,584. This activity coincided with a 26.2% rise in AEHR's stock price, which opened at $33.85 on Thursday, as highlighted by DefenseWorld.net.
Despite a negative P/E ratio of -112.83, AEHR's stock has shown volatility, with a beta of 2.31. The stock's fifty-day simple moving average is $25.02, while the 200-day average is $24.52. Over the past year, AEHR's stock has ranged from a low of $6.27 to a high of $37.49.
In its latest earnings report, AEHR reported a loss of $0.04 per share, better than the expected $0.08 loss. However, the company's revenue of $9.88 million fell short of the $11.45 million analyst estimate. Currently, AEHR's stock is priced at $28.84, with a 3.41% increase, fluctuating between $27.60 and $30.30 during the day.
